Marinus Pharmaceuticals, Inc. (MRNS)

NASDAQ: MRNS · IEX Real-Time Price · USD

1.420

-0.020 (-1.39%)

At close: Apr 25, 2024, 4:00 PM

1.429

+0.009 (0.63%)

After-hours: Apr 25, 2024, 7:45 PM EDT

Marinus Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2012
Net Income	-141.41	-19.82	-98.78	-76.36	-54.12	-36.73	-18.9	-28.64	-24.85	-13.38	Upgrade
Depreciation & Amortization	0.74	0.67	0.67	0.6	0.5	0.13	0.13	0.02	0.01	0.01	Upgrade
Share-Based Compensation	15.56	14.89	13.87	7.64	5.67	4.79	2.88	3.08	2.11	0.7	Upgrade
Other Operating Activities	7.1	-108.63	28.77	-1.68	-0.69	3.97	-2.92	0.77	2.6	1.54	Upgrade
Operating Cash Flow	-118	-112.89	-55.48	-60.91	-48.63	-27.84	-18.82	-24.77	-20.13	-8.59	Upgrade
Capital Expenditures	-0.11	-1.6	-2.89	0	-0.39	-0.08	-0.45	-0.64	-0.35	-0.03	Upgrade
Acquisitions	0	107.38	0	0	0	0	0	0	0	0	Upgrade
Change in Investments	-28.5	0	1.47	-0.74	4.27	20	-20.97	2.04	-5.96	0	Upgrade
Investing Cash Flow	-28.61	105.77	-1.42	-0.74	3.88	19.92	-21.42	1.4	-6.31	-0.03	Upgrade
Share Issuance / Repurchase	26.63	66.27	1.2	109.22	67.97	42.31	52.64	-0.04	0.17	41.33	Upgrade
Debt Issued / Paid	0	58.51	40.26	0	0	-0.19	-5.05	-2.13	28.28	6.98	Upgrade
Other Financing Activities	-	-0.04	-0.15	-	-	-	-	-	-	-	Upgrade
Financing Cash Flow	26.63	124.74	41.31	109.22	67.97	42.12	47.59	-2.17	28.45	48.31	Upgrade
Net Cash Flow	-119.98	117.62	-15.58	47.57	23.22	34.2	7.35	-25.54	2	39.68	Upgrade
Free Cash Flow	-118.11	-114.49	-58.37	-60.91	-49.02	-27.93	-19.27	-25.41	-20.48	-8.62	Upgrade
Free Cash Flow Margin	-381.14%	-449.36%	-380.36%	-3545.52%	-	-	-	-	-	-	Upgrade
Free Cash Flow Per Share	-2.20	-2.93	-1.59	-2.23	-3.60	-2.73	-3.27	-5.21	-5.49	-5.61	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).